Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study

200456 citationsJournal Article

Authors

E Martí Guadaño · Clave (Brazil)

Joan Serra-Batllés · Victoria General Hospital

Juan Meseguer · Hospital General Universitari de Castelló

José A. García del Castillo

Montserrat Molina

Antonio Valero · Universitat de Barcelona

César Picado · Universitat de Barcelona

Rupatadine Study Group ·

Abstract

Rupatadine 10 mg once daily was clearly superior to placebo in alleviating the symptoms of SAR over a 2-week period. In comparison with ebastine, rupatadine shows a trend towards a better profile as regard several secondary efficacy variables.

Topics & Keywords

Allergic Rhinitis and Sensitization Asthma and respiratory diseases Respiratory and Cough-Related Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Allergy

Volume 59, Issue 7, pp. 766-771

DOI: 10.1111/j.1398-9995.2004.00576.x

Field-Weighted Citation Impact: 1.37